AnaBios Corp-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:AnaBios Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011887
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
AnaBios Corp (AnaBios) is a pre-clinical stage contract research organization which carries out drug efficacy studies on human samples. Its products portfolio includes human dorsal root ganglia (hDRG) neuron cultures, human heart tissue samples,human cardiac mesenchymal stem cells, human brain tissue samples, human lung samples, human eye samples, human retinal cell cultures, human spinal cord tissue samples and others. The company provides its products in the therapeutic areas of pain, cardiac, central nervous system, respiratory and ophthalmic. AnaBios offers services which include imaging-based drug profiling, electrophysiology-based drug profiling, myocardial tissue contractility, inhibition of NGF signaling pathway, drug safety services among others. The company employs Phase-X proprietary technology for drug discovery. It serves biotechnology and pharmaceutical industries. AnaBios is headquartered in San Diego, California, the US.

AnaBios Corp – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
AnaBios Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
AnaBios Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
AnaBios Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
AnaBios Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
AnaBios Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
AnaBios Corp, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
AnaBios Raises USD10 Million in Series B Financing 10
AnaBios Raises USD3.6 Million Financing 11
AnaBios Secures US$0.8 Million In Series A Financing Round 12
Partnerships 13
Purdue Pharma to Form Joint Venture with AnaBios 13
Licensing Agreements 14
Purdue Pharma Enters into Licensing agreement with AnaBios 14
Zalicus Enters into Licensing Agreement with AnaBios for Sodium Channel Pain Modulation Program 15
AnaBios Corp – Key Competitors 16
AnaBios Corp – Key Employees 17
AnaBios Corp – Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
AnaBios Corp, Pharmaceuticals & Healthcare, Key Facts 2
AnaBios Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
AnaBios Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
AnaBios Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
AnaBios Corp, Deals By Therapy Area, 2011 to YTD 2017 8
AnaBios Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
AnaBios Raises USD10 Million in Series B Financing 10
AnaBios Raises USD3.6 Million Financing 11
AnaBios Secures US$0.8 Million In Series A Financing Round 12
Purdue Pharma to Form Joint Venture with AnaBios 13
Purdue Pharma Enters into Licensing agreement with AnaBios 14
Zalicus Enters into Licensing Agreement with AnaBios for Sodium Channel Pain Modulation Program 15
AnaBios Corp, Key Competitors 16
AnaBios Corp, Key Employees 17

★海外企業調査レポート[AnaBios Corp-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Petro Welt Technologies AG (O2C):企業の財務・戦略的SWOT分析
    Petro Welt Technologies AG (O2C) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • The Nature’s Bounty Co.:戦略・SWOT・企業財務分析
    The Nature’s Bounty Co. - Strategy, SWOT and Corporate Finance Report Summary The Nature’s Bounty Co. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Just Energy Group Inc. (JE):企業の財務・戦略的SWOT分析
    Just Energy Group Inc. (JE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • The Cooper Companies Inc (COO):企業の財務・戦略的SWOT分析
    The Cooper Companies Inc (COO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Spicers Limited (SRS):企業の財務・戦略的SWOT分析
    Spicers Limited (SRS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Ergomed Plc (ERGO):企業の財務・戦略的SWOT分析
    Summary Ergomed Plc (Ergomed), formerly Ergomed Clinical Research Ltd, is a drug development and clinical research services provider. The company provides various services such as regulatory and quality management, biostatistics, study management, clinical data management, medical writing, and other …
  • Bengal Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Bengal Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Bengal Energy Ltd (Bengal Energy), formerly Avery Resources Inc is an oil and gas exploration and production company that acquires, explores, and produces prospective light oil-weighted onshore assets …
  • Printpack, Inc.:戦略・SWOT・企業財務分析
    Printpack, Inc. - Strategy, SWOT and Corporate Finance Report Summary Printpack, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Aero Precision Industries, Inc.:企業の戦略・SWOT・財務情報
    Aero Precision Industries, Inc. - Strategy, SWOT and Corporate Finance Report Summary Aero Precision Industries, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Werner Enterprises, Inc. (WERN):企業の財務・戦略的SWOT分析
    Werner Enterprises, Inc. (WERN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Global Foundries Inc:企業のM&A・事業提携・投資動向
    Global Foundries Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Global Foundries Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • First Solar Inc (FSLR):電力:M&Aディール及び事業提携情報
    Summary First Solar Inc (First Solar) is a provider of comprehensive photovoltaic (PV) solar systems. It designs, manufactures, and sells PV solar modules. The company produces solar systems using cadmium telluride technology. First Solar also develops, designs, constructs, and sells PV solar power …
  • North Eastern Electric Power Corporation Ltd:企業の戦略的SWOT分析
    North Eastern Electric Power Corporation Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …
  • Panacea Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Panacea Pharmaceuticals Inc (Panacea) is a clinical stage biopharmaceutical company that discovers, develops and commercializes therapeutic and diagnostic products for the treatment of cancer and central nervous system diseases. The company’s pipeline products include PAN-301-1, a human aspa …
  • Invenra Inc-製薬・医療分野:企業M&A・提携分析
    Summary Invenra Inc (Invenra) is a healthcare services provider that offers therapeutic solutions. The company discovers therapeutic human antibodies and their derivatives. It uses its proprietary technology to combine the ribosome display, cell free expression of antibodies with miniaturization, mi …
  • The British United Provident Association Limited:企業の戦略・SWOT・財務分析
    The British United Provident Association Limited - Strategy, SWOT and Corporate Finance Report Summary The British United Provident Association Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, …
  • Petron Corp (PCOR):石油・ガス:M&Aディール及び事業提携情報
    Summary Petron Corp (Petron), a subsidiary of San Miguel Corporation, is a downstream energy company. It refines and markets an array of petroleum products including gasoline, liquefied petroleum gas, diesel, jet fuel, kerosene, industrial fuel oil, solvents, asphalts; and petrochemical feedstocks s …
  • The Tata Power Co Ltd (TATAPOWER):企業の財務・戦略的SWOT分析
    The Tata Power Co Ltd (TATAPOWER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Adimab LLC-製薬・医療分野:企業M&A・提携分析
    Summary Adimab LLC (Adimab) is an antibody discovery technology provider that offers antibody discovery and optimization platform. The company discovers antibodies for a range of disease areas including oncology, immunomodulation, neuroscience and pain, inflammation, cardiovascular and metabolic dis …
  • McKinsey & Co Inc:企業の戦略的SWOT分析
    McKinsey & Co Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆